INM

Inmed Pharmaceuticals Inc

0.8852

-0.0048-0.54%

Opening11:04 03/18 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE0.7795/0.8200

TODAY RANGE0.7311-0.8332

VOL1.13M

MARKET CAP2.29M

52 WEEK RANGE0.7311-7.98

AVG VOL (3M)86.25K

% TURNOVER38.87%

TURNOVER--

P/E (TTM)-0.1923

% RANGE12.45%

EPS(TTM)-4.0832

P/E(FORWARD)-0.0016

P/B0.2296

BVPS3.419

DIVIDEND--

P/S0.3180

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.29M

SHARES OUTSTANDING2.92M

NEXT EARNINGS05/11-05/15

FREE FLOAT2.92M

LOT SIZE1

EX-DATE11/14/2024

News

Press Releases

Financial Reports

Profile

TipRanks·03/09 12:06
InMed outlines 2026 development plans for lead programs
TipRanks·03/09 12:01
InMed Pharmaceuticals provides development outlook for 2026
Reuters·03/09 11:31
InMed targets 2027 Phase 1 trial start for INM-901 and plans FDA pre-IND meeting in Q3 2026
TipRanks·03/06 22:21
InMed Pharmaceuticals Exits BayMedica to Refocus on Pipeline
Reuters·03/06 22:06
InMed winds down BayMedica commercial operations to focus on drug development pipeline
Reuters·03/06 21:59
INMED PHARMACEUTICALS INC - BAYMEDICA TO COMPLETE WIND DOWN BEFORE FISCAL YEAR ENDING JUNE 30, 2026 - SEC FILING
Reuters·03/06 21:58
InMed pro forma net loss widens 18% to $8.83 million for FY2025
TipRanks·02/12 11:32
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
Reuters·02/12 11:04
InMed Pharmaceuticals Inc. Q2 BayMedica revenue drops 26% to USD 0.8 million
Reuters·02/11 22:05
InMed Pharma Q4 R&D expenses USD 0.63 million, down 30%
TipRanks·12/18/2025 17:20
InMed Shareholders Approve Directors and Equity Financing Flexibility
Reuters·12/18/2025 01:01
InMed Pharmaceuticals Inc. Held Annual Shareholder Meeting
TipRanks·12/15/2025 14:57
InMed Faces Challenges from New U.S. Legislation
Reuters·12/15/2025 14:37
INMED PHARMACEUTICALS INC - BAYMEDICA EVALUATING ALTERNATIVE SUPPLY CHAIN OPTIONS - SEC FILING
Reuters·12/15/2025 14:37
INMED PHARMACEUTICALS INC - EXPECTS NEGATIVE IMPACT ON BAYMEDICA FROM NEW ACT H.R. 5371 - SEC FILING

Same Industry

Name/Symbol

Change%

Price

Inmed Pharmaceuticals Inc

INM

-0.54%

0.8852

REGN

GridAI Tech

GRDX

-1.83%

2.140

BIONTECH

BNTX

+4.77%

94.86

UTHR

SIGA

Vertex Pharmaceuticals Inc

VRTX

-2.39%

451.42

Moderna

MRNA

+1.16%

53.93

CRL

MEDP

TLPH

CBPO

ICLR

IQV

MOLECULAR PARTNERS AG

MOLN

+4.72%

4.545

GILD

ARCT

PRAH

Incyte Corp

INCY

+0.77%

92.95

APVO

Biospecifics

BSTC

+0.15%

88.53

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.